Research programme: anticancer therapeutic vaccine - Vedantra Precision ImmunityAlternative Names: ALK-ICMVs; E6-ICMVs; E7-ICMVs
Latest Information Update: 02 Sep 2016
At a glance
- Originator Vedantra Precision Immunity
- Class Immunotherapies; Vaccines
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; Human papillomavirus E6 protein inhibitors; Human papillomavirus E7 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 01 Sep 2016 Preclinical trials in Cancer in USA (Parenteral) before September 2016